NCT04664894View on ClinicalTrials.gov

Direct Acting Anti-Viral's In Chronic HCV Patients

CompletedOBSERVATIONAL

Enrollment

511

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

May 30, 2019

Conditions

Safety Issues

Interventions

DRUG

Sofosbuvir

the occurrence of AEs (AE) and their severity among chronic HCV patients has assessed in patinets receiving different combinations of DAAs in Pakistani Population

Trial Locations (1)

Unknown

Liver Center Faisalabad, Faisalabad